Bruker Stock Buy Hold or Sell Recommendation
| BRKR Stock | USD 56.88 2.13 3.61% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Bruker is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Bruker within the specified time frame.
Check out Bruker Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide. Note, we conduct extensive research on individual companies such as Bruker and provide practical buy, sell, or hold advice based on investors' constraints. Bruker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
Bruker |
Execute Bruker Buy or Sell Advice
The Bruker recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bruker. Macroaxis does not own or have any residual interests in Bruker or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bruker's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Bruker Trading Alerts and Improvement Suggestions
| Bruker generated a negative expected return over the last 90 days | |
| Bruker is unlikely to experience financial distress in the next 2 years | |
| Over 80.0% of the company shares are held by institutions such as insurance companies | |
| On 16th of December 2024 Bruker paid $ 0.05 per share dividend to its current shareholders | |
| Latest headline from news.google.com: Does Bruker Have A Healthy Balance Sheet - Simply Wall St |
Bruker Returns Distribution Density
The distribution of Bruker's historical returns is an attempt to chart the uncertainty of Bruker's future price movements. The chart of the probability distribution of Bruker daily returns describes the distribution of returns around its average expected value. We use Bruker price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bruker returns is essential to provide solid investment advice for Bruker.
| Mean Return | -0.12 | Value At Risk | -4.2 | Potential Upside | 4.22 | Standard Deviation | 2.80 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bruker historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bruker Stock Institutional Investors
The Bruker's institutional investors refer to entities that pool money to purchase Bruker's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Brown Advisory Holdings Inc | 2024-09-30 | 1.8 M | Alyeska Investment Group, L.p. | 2024-09-30 | 1.5 M | Ameriprise Financial Inc | 2024-09-30 | 1.5 M | Td Asset Management Inc | 2024-09-30 | 1.5 M | Bank Of America Corp | 2024-09-30 | 1.4 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.4 M | Norges Bank | 2024-06-30 | 1.1 M | Amvescap Plc. | 2024-09-30 | 1 M | Bank Of New York Mellon Corp | 2024-09-30 | 919.1 K | Fmr Inc | 2024-09-30 | 14.3 M | T. Rowe Price Investment Management,inc. | 2024-09-30 | 13 M |
Bruker Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (87.9M) | (67M) | (140.1M) | (125M) | (112.5M) | (106.9M) | |
| Change In Cash | 3.6M | 386.2M | (423M) | (157.1M) | (180.7M) | (171.6M) | |
| Free Cash Flow | 235M | 190.4M | 143M | 243.2M | 279.7M | 293.7M | |
| Depreciation | 80.4M | 89.1M | 88M | 114.9M | 132.1M | 138.7M | |
| Other Non Cash Items | 24.8M | 26.5M | 8.1M | (103.8M) | (119.4M) | (113.4M) | |
| Capital Expenditures | 98.2M | 92M | 119M | 106.9M | 122.9M | 129.1M | |
| Net Income | 161.4M | 280.6M | 298.5M | 427.2M | 491.3M | 515.8M | |
| End Period Cash Flow | 685.5M | 1.1B | 648.7M | 491.6M | 565.3M | 312.4M | |
| Change To Netincome | 4.2M | (6.5M) | 41.4M | 12.9M | 11.6M | 12.5M | |
| Dividends Paid | 24.6M | 24.2M | 29.8M | 29.4M | 33.8M | 19.1M | |
| Change Receivables | (5M) | 40.8M | (95.3M) | (67.9M) | (61.1M) | (58.1M) | |
| Net Borrowings | 462.6M | (8.4M) | 489.6M | 300K | 345K | 327.8K | |
| Investments | (36.5M) | (50.3M) | (239.3M) | (438.5M) | (394.7M) | (374.9M) |
Bruker Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bruker or Life Sciences Tools & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bruker's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bruker stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | 0.29 | |
σ | Overall volatility | 2.83 | |
Ir | Information ratio | -0.06 |
Bruker Volatility Alert
Bruker exhibits very low volatility with skewness of 0.76 and kurtosis of 2.32. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bruker's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bruker's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bruker Fundamentals Vs Peers
Comparing Bruker's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bruker's direct or indirect competition across all of the common fundamentals between Bruker and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bruker or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bruker's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bruker by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bruker to competition |
| Fundamentals | Bruker | Peer Average |
| Return On Equity | 0.2 | -0.31 |
| Return On Asset | 0.0483 | -0.14 |
| Profit Margin | 0.09 % | (1.27) % |
| Operating Margin | 0.10 % | (5.51) % |
| Current Valuation | 10.89 B | 16.62 B |
| Shares Outstanding | 151.6 M | 571.82 M |
| Shares Owned By Insiders | 31.91 % | 10.09 % |
| Shares Owned By Institutions | 80.08 % | 39.21 % |
| Number Of Shares Shorted | 6.2 M | 4.71 M |
| Price To Earning | 67.10 X | 28.72 X |
| Price To Book | 4.77 X | 9.51 X |
| Price To Sales | 2.76 X | 11.42 X |
| Revenue | 2.96 B | 9.43 B |
| Gross Profit | 1.62 B | 27.38 B |
| EBITDA | 599 M | 3.9 B |
| Net Income | 427.2 M | 570.98 M |
| Cash And Equivalents | 733.6 M | 2.7 B |
| Cash Per Share | 4.95 X | 5.01 X |
| Total Debt | 1.38 B | 5.32 B |
| Debt To Equity | 1.20 % | 48.70 % |
| Current Ratio | 2.55 X | 2.16 X |
| Book Value Per Share | 11.92 X | 1.93 K |
| Cash Flow From Operations | 350.1 M | 971.22 M |
| Short Ratio | 4.86 X | 4.00 X |
| Earnings Per Share | 2.00 X | 3.12 X |
| Price To Earnings To Growth | 3.64 X | 4.89 X |
| Target Price | 73.8 | |
| Number Of Employees | 9.71 K | 18.84 K |
| Beta | 1.2 | -0.15 |
| Market Capitalization | 8.95 B | 19.03 B |
| Total Asset | 4.25 B | 29.47 B |
| Retained Earnings | 2.32 B | 9.33 B |
| Working Capital | 962.1 M | 1.48 B |
Note: Acquisition by Frank Laukien of 69866 shares of Bruker at 49.82 subject to Rule 16b-3 [view details]
Bruker Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bruker . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bruker Buy or Sell Advice
When is the right time to buy or sell Bruker? Buying financial instruments such as Bruker Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bruker in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Risk ETFs Thematic Idea Now
Target Risk ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.